Endogenous adenosine contributes to renal sympathetic neurotransmission via postjunctional A1 receptor-mediated coincident signaling

American Journal of Physiology - Renal Physiology

Volumn 302, Issue 4, 2012, Pages

  Jackson, Edwin K ^a   Cheng, Dongmei ^a   Tofovic, Stevan P ^a   Mi, Zaichuan ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine receptors; Kidney; Norepinephrine

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,3 DIPROPYL 8 4 SULFOPHENYLXANTHINE; 2 (2 HYDROXYETHYL) 1 [3 (2 PHENYLPYRAZOLO[1,5 A]PYRIDIN 3 YL)ACRYLOYL]PIPERIDINE; 2 AMINO N [4 [5 (2 PHENANTHRENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]PHENYL]ACETAMIDE; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; FR 113452; N (4 CYANOPHENYL) 2 [4 (2,3,6,7 TETRAHYDRO 2,6 DIOXO 1,3 DIPROPYL 1H PURIN 8 YL)PHENOXY]ACETAMIDE; NORADRENALIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOLIPASE C; PROTEIN KINASE C; UNCLASSIFIED DRUG; VUF 5574; WORTMANNIN; XANTHINE DERIVATIVE;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIURETIC ACTIVITY; KIDNEY; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; MALE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 84856741311     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00495.2011     Document Type: Article

References (35)

1. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11: 150-155, 1990.
2. Bekersky I. Use of the isolated perfused kidney as a tool in drug disposition studies. Drug Metab Rev 14: 931-960, 1983.
3. Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ, Bunting S. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther 255: 756-768, 1990.
4. 2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway. Am J Physiol Renal Physiol 291: F155-F161, 2006.
5. q and acceleration is inhibited by Gβ subunits. J Biol Chem 274: 19639-19643, 1999.
6. 1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail 14: 631-640, 2008.
7. Coulson R, Johnson RA, Olsson RA, Cooper DR, Scheinman SJ. Adenosine stimulates phosphate and glucose transport in opossum kidney epithelial cells. Am J Physiol Renal Fluid Electrolyte Physiol 260: F921-F928, 1991.
8. 1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. J Card Fail 13: 609-617, 2007.
9. Docherty JR. Subtypes of functional α1-adrenoceptor. Cell Mol Life Sci 67: 405-417, 2010.
10. Dubinion JH, Mi Z, Jackson EK. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther 317: 1330-1336, 2006.
11. Dubinion JH, Mi Z, Zhu C, Gao L, Jackson EK. Pancreatic polypeptide-fold peptide receptors and angiotensin II-induced renal vasoconstriction. Hypertension 47: 545-551, 2006.
12. Ekas RD Jr, Steenberg ML, Eikenburg DC, Lokhandwala MF. Presynaptic inhibition of sympathetic neurotransmission by adenosine in the rat kidney. Eur J Pharmacol 76: 301-307, 1981.
13. Ekas RD Jr, Steenberg ML, Lokhandwala MF. Increased norepinephrine release during sympathetic nerve stimulation and its inhibition by adenosine in the isolated perfused kidney of spontaneously hypertensive rats. Clin Exp Hypertens 5: 41-48, 1983.
14. Eppel GA, Ventura S, Denton KM, Evans RG. Lack of contribution of P2X receptors to neurally mediated vasoconstriction in the rabbit kidney in vivo. Acta Physiol 186: 197-207, 2006.
15. 2B receptor activation. Am J Physiol Renal Physiol 299: F310-F315, 2010.
16. Fredholm BB, Duner-Engstrom M, Fastbom J, Hu PS, van der Ploeg I. Role of G proteins, cyclic AMP, and ion channels in the inhibition of transmitter release by adenosine. Ann NY Acad Sci 604: 276-288, 1990.
17. 2+-Adrenoceptors potentiate angiotensin IIand vasopressin-induced renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther 305: 581-586, 2003.
18. Givertz MM, Massie BM, Fields TK, Pearson LL, Dittrich HC. The effects of KW-3902, an adenosine A1 receptor antagonist, on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. J Am Coll Cardiol 50: 1551-1560, 2007.
19. Guan Z, Osmond DA, Inscho EW. P2X receptors as regulators of the renal microvasculature. Trends Pharmacol Sci 28: 646-652, 2007.
20. Guan Z, Osmond DA, Inscho EW. Purinoceptors in the kidney. Exp Biol Med (Maywood) 232: 715-726, 2007.
21. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. J Biol Chem 271: 695-701, 1996.
22. Hansen PB, Castrop H, Briggs J, Schnermann J. Adenosine induces vasoconstriction through Gi-dependent activation of phospholipase C in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 14: 2457-2465, 2003.
23. Hedqvist P, Fredholm BB. Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and postjunctional enhancement. Naunyn Schmiedebergs Arch Pharmacol 293: 217-223, 1976.
24. Hedqvist P, Fredholm BB, Olundh S. Antagonistic effects of theophylline and adenosine on adrenergic neuroeffector transmission in the rabbit kidney. Circ Res 43: 592-598, 1978.
25. Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HHHW, Busse R, Schroder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51: 211-217, 2008.
26. Hocher B. Adenosine A1 receptor antagonists in clinical research and development. Kidney Int 78: 438-445, 2010.
27. 1 receptor blocker SLV329 in experimental liver cirrhosis in rats. PLos One 6: e17891, 2011.
28. Inscho EW, Cook AK, Clarke A, Zhang S, Guan Z. P2X1 receptormediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet. Hypertension 57: 780-787, 2011.
29. 1 receptor antagonists as diuretic/natriuretic agents. Drugs Future 27: 1057-1069, 2002.
30. Jackson EK. P1 and P2 receptors in the renal system. In: Handbook of Experimental Pharmacology Volume 151/II; Purinergic and Pryimidinergic Signalling II: Cardiovascular, Respiratory, Immune, Metabolic and Gastrointestinal Tract Function, edited by Abbrachio M and Williams M. Berlin: Springer-Verlag, 2001, p. 33-71.
31. Jackson EK. Role of adenosine in noradrenergic neurotransmission in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 253: H909-H918, 1987.
32. 2+-adrenoceptor interaction. J Pharmacol Exp Ther 314: 1109-1116, 2005.
33. 2+-Adrenoceptors enhance angiotensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA. Hypertension 51: 719-726, 2008.
34. Jackson EK, Mi ZC. Sitagliptin augments sympathetic enhancement of the renovascular effects of angiotensin II in genetic hypertension. Hypertension 51: 1637-1642, 2008.
35. Jackson EK, Zhang M, Liu W, Mi Z. Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-induced potentiation of angiotensin II-mediated renal vasoconstriction in spontaneously hypertensive rats. J Pharmacol Exp Ther 323: 431-437, 2007.